Tirzepatide
Tirzepatide is a synthetic dual agonist peptide engineered to simultaneously activate GLP-1 and GIP receptors, integrating incretin-based signaling pathways for advanced metabolic research.
Tirzepatide is positioned as a precision dual-agonist system, delivering synchronized incretin signaling for enhanced metabolic control. It represents a refined advancement beyond single-pathway peptides, offering a balanced approach to glucose regulation and energy metabolism in high-level research environments.
Molecular Specifications
-
Type: Synthetic dual agonist peptide (GLP-1 / GIP)
-
Length: 39 amino acids
-
Molecular Weight: ~4813 g/mol (~4.8 kDa)
-
Structure: Modified incretin analog with lipidation (fatty-acid side chain)
-
Key Features: DPP-4 resistance, albumin binding, extended half-life
-
Solubility: Water-soluble
-
Charge Profile: pH-dependent
-
Stability: Sensitive to heat, light, and oxidation
RESEARCH USE ONLY (RUO): THIS COMPOUND IS FOR LABORATORY RESEARCH USE ONLY. NOT FOR HUMAN CONSUMPTION, VETERINARY, OR DIAGNOSTIC PURPOSES.
